ルベル・インターナショナル病院
| トルコ | オーストリア | スペイン | |
| 顔面神経修復術 | から $4,200 | から $12,000 | から $8,000 |
| 鼓室内ステロイド注射 | から $250 | から $800 | から $600 |
Bookimedは顔面神経修復術価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで顔面神経修復術代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。顔面神経修復術で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。顔面神経修復術の旅路でお一人になることはありません。
Dr. Bugra Bilge Keseroglu specializes in robotic and laparoscopic urology. His robotic work includes radical prostatectomy (conventional and Retzius-sparing), radical cystectomy, sacrocolpopexy, and Burch colposuspension. His laparoscopic work includes radical prostatectomy with lymph node dissection, radical cystectomy, sacrocolpopexy, and Burch colposuspension. He also performs laparoscopic nephrectomy and partial nephrectomy, pyeloplasty, all endourological surgeries (stone surgery and endoscopic procedures), HOLEP, and female incontinence surgery.
Education: Uludağ University Faculty of Medicine, 1990–1996. Specialization: S.B. Ankara Training and Research Hospital, 1997–2002. Experience: Yozgat State Hospital, 2002–2006 and 2012–2016; Yozgat Private Hospital, 2006–2011; S.B. Ankara Training and Research Hospital, 2016–2019; Bilkent City Hospital, 2019–2024.
Dr. Bao Yuhai is a Professor and Chief Physician of Neurosurgery. He is a pioneer and leading figure in the field, a distinguished professor, and a doctoral supervisor. He has received the State Council Special Allowance, one of China’s highest clinical honors. He is Director of the Neurosurgical Oncology Center at Xuanwu Hospital. He serves on WFNS committees. He is Associate Editor-in-Chief for Interventional Neuroradiology and serves on several journal editorial boards.
With more than 40 years in practice, he specializes in acoustic neuromas, meningiomas, pituitary adenomas, craniopharyngiomas, and gliomas. He also treats trigeminal neuralgia, hemifacial spasm, and brainstem tumors. His work includes cerebral aneurysms, vascular malformations, and spinal vascular malformations. After total acoustic neuroma resection, he preserves facial nerve function in over 95% of cases.
He has contributed to 4 national clinical guidelines. He has taken part in international multicenter studies. He holds 2 national invention patents and 2 utility patents. He has published over 80 academic papers.
Dr. Halil Can is a Professor of Neurosurgery (2025; Associate Professor 2020). He completed neurosurgical training at Istanbul University–Istanbul Faculty of Medicine in 2007. His clinical focus includes endoscopic and microsurgical spine surgery for fractures, tumors, and degenerative disease; advanced pain procedures; endoscopic skull base and pituitary surgery; and neurovascular, neuro-oncologic, and peripheral nerve surgery.
He has 21 international peer-reviewed papers (SCI/SSCI). Topics include cadaveric morphometry of Kambin’s triangle and the transforaminal triangular working zone, lumbar arterial and anterior approach anatomy, and an in vitro test of a new lumbar fixation device.
His clinical studies include a single-team series of 81 posterior circulation aneurysms, with 13 flow-diversion cases. He also reported five spinal cavernous malformation cases. He conducted Phase I safety and feasibility stem-cell trials in pediatric hypoxic-ischemic encephalopathy and in chronic complete spinal cord injury.
Dr. Ulvi Samadzade is a neurologist with training from Azerbaijan State Medical University, Gazi University, and Dokuz Eylul University Hospital. He diagnoses and treats neurological disorders such as Alzheimer’s disease, epilepsy, movement disorders, stroke, migraine, and multiple sclerosis.
Dr. Samadzade uses advanced treatments, including botulinum toxin injections, intravenous immunoglobulin (IVIG) therapy, migraine vaccines, and plasmapheresis. He practices at İzmir University of Economics Medical Point Hospital.
He is a member of several professional organizations. These include the Multiple Sclerosis Research Association, Turkish Neurological Society, European Academy of Neurology, and the International Parkinson and Movement Disorder Society (MDS).